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ABSTRACT 
The efficacy of zeolite as anticancer adjuvant is unclear, but natural zeolite 
clinoptilolite has been proven to have antiproliferation activity against cancer cells.  
This research investigated the potential of synthetic nanozeolite as anticancer 
adjuvant in vitro.  Initial study proved the antiproliferation abilities of zeolite NaY 
(Zeo-NaY), commercial zeolite Y (CBV300) and beta (CP814E) against six types of 
cancer cells through 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide 
(MTT) assay.  The aim of this research was to synthesize nanozeolite NaY (Nano-
NaY) with higher antiproliferation activity and tolerance to gastrointestinal condition 
using organotemplate-free method and rice husk ash (RHA) as the silica source.  The 
newly-synthesized Nano-NaY was characterized by X-ray diffraction (XRD), Fourier 
transform infra-red (FTIR) spectroscopy, field emission scanning electron 
microscopy (FESEM), transmission electron microscopy (TEM) and surface area 
analysis. Structural stability of Nano-NaY was tested in simulated gastric fluid (SGF) 
and intestinal fluid (SIF) at different concentrations by monitoring its characteristic 
and elemental composition (Al3+, Si4+).  Elemental composition (Ca2+, Mg2+) of 
nanozeolite-treated media were analyzed before and after preparation. Cytotoxicity 
of Nano-NaY was tested by MTT assay against colon cancer cells (HT-29) and 
normal liver cells (WRL-68).  Pure Nano-NaY was successfully synthesized with the 
particles sized from 220 nm to 470 nm, and 788 m2/g surface area.  Incubation of 30 
mg/ml Nano-NaY in simulated gastrointestinal fluid (SGIF) resulted in slight 
dealumination of the Nano-NaY, but its structure remained stable.  Reduction of Ca2+ 
and Mg2+ concentrations (35-85%) from nanozeolite-treated media suggested 
adsorption of the cations by Nano-NaY through ionic exchange mechanism.  
Antiproliferation activity and cytotoxicity of Nano-NaY were dependent on its 
micropore surface area (Smicropore), with initial half maximal inhibitory concentration 
(IC50) against HT-29 recorded at 1.26 mg/ml.  The cytotoxicity against WRL-68 after 
incubation in SGIF was low (IC50 = 650 mg/ml).  Thus, Nano-NaY might have the 
potential as an alternative adjuvant therapy for colorectal cancer. 
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ABSTRAK 
Keberkesanan zeolit sebagai pembantu antikanser belum diketahui, tetapi 
zeolit semulajadi telah dibuktikan mempunyai aktiviti antiproliferasi terhadap sel 
kanser.  Penyelidikan ini mengkaji potensi nanozeolite sintetik sebagai pembantu 
antikanser secara in vitro.  Kajian awal membuktikan kebolehan antiproliferasi zeolit 
NaY (Zeo-NaY), zeolit Y komersil (CBV 300) dan zeolit beta komersil (CP814E) 
terhadap enam jenis sel kanser melalui ujian 3, (4,5-dimetilthiazol-2-yl)-2,5-diphenil 
tetrazolium bromida (MTT).  Tujuan kajian ini adalah untuk mensintesis nanozeolit 
NaY (Nano-NaY) yang mempunyai aktiviti antiproliferasi dan toleransi kepada 
keadaan di dalam gastrointestin dengan menggunakan kaedah tanpa-templat-organik 
dan abu sekam padi (RHA) sebagai sumber silika.  Pencirian Nano-NaY yang baru 
ini dibuat melalui kaedah difraksi sinar-X (XRD), spektroskopi inframerah 
transformasi Fourier (FTIR), mikroskopi pancaran pengimbasan electron (FESEM), 
mikroskopi transmisi electron (TEM) dan analisis luas permukaan.  Kestabilan 
struktur Nano-NaY kemudiannya diuji di dalam simulasi cecair gastrik (SGF) dan 
simulasi cecair intestin (SIF) pada kepekatan yang berbeza dengan memerhatikan 
ciri-ciri dan komposisi elemen (Al3+, Si4+) di dalam cecair-cecair tersebut.  
Komposisi elemen (Ca2+, Mg2+) bagi media yang dirawat dengan nanozeolit 
dianalisa sebelum dan selepas penyediaan.  Kesitotoksikan Nano-NaY pula diuji 
melalui ujian MTT terhadap sel kanser kolon (HT-29) dan sel normal hati (WRL-68). 
Nano-NaY tulen telah berjaya disintesis dengan partikel bersaiz dari 220 nm hingga 
470 nm, dan keluasan permukaan sebanyak 788 m2/g.  Inkubasi Nano-NaY sebanyak 
30 mg/ml di dalam cecair simulasi gastrointestin (SGIF) menyebabkan sedikit 
dealuminasi pada Nano-NaY, tetapi strukturnya kekal stabil.  Pengurangan kepekatan 
Ca2+ and Mg2+ (35-85%) daripada media yang dirawat dengan nanozeolit 
mencadangkan penjerapan kation-kation tersebut oleh Nano-NaY melalui 
mekanisme pertukaran ion.  Aktiviti antiproliferasi dan sitotoksisiti Nano-NaY 
bergantung kepada luas permukaan liang-mikro (Sliang-mikro), dengan kepekatan 
perencatan separuh maksima (IC50) ke atas HT-29 direkod pada 1.26 mg/ml.  
Sitotoksisiti ke atas WRL-68 selepas inkubasi di dalam SGIF adalah rendah (IC50 = 
650 mg/ml).  Dengan itu, Nano-NaY mempunyai potensi sebagai satu terapi 
alternatif yang mungkin bagi kanser kolorektal. 
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CHAPTER 1 
INTRODUCTION 
1.1 Background of Research 
Cancer refers to the condition of an uncontrolled growth of cells which will 
invade and destroy the cell functions, particularly the main organs.  It has been one 
of the major cause of deaths in the world.  There are many factors that may 
contribute to the rise of cancer cases such as genetic hereditary, tobacco, unhealthy 
diet, lack of physical activities, ultraviolet (UV), radiation and prolonged exposures 
to carcinogens (Vogelstein and Kinzler, 2004; Ezzati et al., 2005; Sankpal et al., 
2012).  Historically, surgery was the only way to treat cancer but now it is limited to 
certain cases like primary tumor treatment, metastases resection and staging 
purposes. 
Cancer staging is essential in order to identify the extent of the disease and in 
selecting the best treatment regime for the patient.  The most common staging system 
is the tumor node metastasis (TNM) system (Edge and Compton, 2010).  Cancer 
diagnosis and staging is normally confirmed by biopsy.  The samples obtained will 
be sent to the laboratory where they will be examined, processed and stained using 
immunohistochemistry method.  A pathologist will generate a cytology and 
histopathology report before the oncologist can decide and initiate the necessary 
treatment.  
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There are many available choices of treatment nowadays besides surgery 
such as chemotherapy, radiotherapy, targeted therapy, hyperthermia, stem cell 
transplant and photodynamic therapy.  The choice of treatments, however, depends 
on the type of cancer and its classification (World Health Organization, 2008; 
Ministry of Health Malaysia, 2002 and 2003).  Combined treatments may be 
arranged through neoadjuvant therapy or adjuvant therapy to ensure the effectiveness 
of the main treatment.  Neoadjuvant therapy is normally given prior to surgery in 
order to shrink the tumor beforehand.  On the other hand, adjuvant therapy is a 
systemic therapy that is given to the patients after the main treatment particularly for 
those with a high risk of recurrence.  The objective is to prevent tumor cells 
progression and boost the immune system so the patients will be able to live long and 
comfortable life despite the disease. 
Even with ample choices given, there are restrictions to the available 
treatments.  One example is the possibility of recurrence after surgery (Snyder and 
Greenberg, 2010), meaning that cancer may come back after treatment at the same 
site (local) or at a different site (distant).  Another major concern is drug resistance in 
chemotherapy through adaptation of the tumor cells to the given drugs (Casanovas, 
2012).  Cancer treatment by radiotherapy is useful for localized cancer but may 
affect the normal cells nearby, while treatments by hyperthermia and stem cell 
transplant have yet to prove their effectiveness in clinical studies.  With all the 
limitations at hand and no definite cure as yet, the use of adjuvant therapy is very 
much relied on, although it means that patients have to suffer the immediate side 
effects or the delayed late toxicity.  Therefore, a research on new potential anticancer 
adjuvant that possesses good anticancer activity with fewer side effects or toxicity is 
very much anticipated. 
Zeolite was first discovered by Cronstedt in 1756 with the discovery of 
stilbite (Breck, 1974).  The term zeolite comes from two Greek words, “zeo” (to boil) 
and “lithos” (stone).  Zeolite is an aluminosilicate with a relatively open framework 
due to its porous structure.  The zeolite framework consists of Si-O tetrahedral 
complex and at some places in the framework the Si4+ is replaced by Al3+.  This 
results in a negative framework charge which is due to the deficiency of an electron 
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at the Al-O tetrahedral (Maesen and Marcus, 2001).  Charge-compensating cation 
from the alkali or alkaline earth metals enters the pore to maintain the 
electroneutrality of the overall zeolite framework.  However, the molecules entering 
the pore would be selectively sieved by the size of each molecule.  These unique 
properties contribute to the major function of zeolites as catalysts, ion exchangers 
and adsorbents with vast application in many industries.  Thus, this research 
investigated on the potential of using a newly-synthesized nanozeolite NaY in 
biomedical application as an alternative adjuvant therapy for cancer. 
1.2 Problem Statements 
The revelation of natural zeolite, clinoptilolite, as an anticancer adjuvant that 
is able to inhibit the growth of cancer cells and promotes longer lifespan with low 
side effects is appreciated (Pavelic et al., 2001).  However, natural zeolites contain 
impurities from the open environment.  Variation in the mineral composition of the 
natural zeolite may result in diverse levels of anticancer activity which will make 
dosage determination difficult.  Therefore, a purification process of natural zeolites is 
necessary before any biomedical application.  Unfortunately, it does not ensure 
complete extraction of the unwanted minerals (Tomasevic-Canovic, 2005).  Unless a 
complete preliminary characterization is made and the zeolite material is 
standardized, the use of natural zeolites in biomedical application should be 
reconsidered as natural zeolites are poor materials to begin with (Colella, 2011). 
A possible alternative to natural zeolites is the synthetic zeolites.  Synthetic 
zeolites will ensure standardization in the matter of purity, size distribution, cationic 
composition and the production procedures.  Synthesis of zeolite generates zeolites 
that are engineered to the desired form and provides rooms for modification in order 
to enhance the capability of the zeolites for the intended application.  For example, 
decreasing the size of the zeolites to nanoscale will create larger surface area, expose 
more active sites and reduce diffusion path lengths, thus, will increase the activity of 
the zeolites (Mintova et al., 2013).  Napierska et al. (2009) had proven the inverse 
relationship between particle size and cytotoxicity of monodisperse silica 
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nanoparticles.  Most methods for the preparation of synthetic nanozeolites, however, 
require the use of huge quantity of organic templates which is not environmentally 
friendly and costly.  Modification through green methods by fine controlling the 
nucleation and adjusting the growth steps through chemical or physical conditions 
may help to reduce the use of environmental hazards in the synthesis process 
(Mintova et al., 2013; Ng et al., 2012a). 
The use of rice husk ash (RHA) as silica source alternatively promotes waste 
materials to wealth (Della et al., 2002).  More than 90% of amorphous silica can be 
obtained from the combustion of rice husk at high temperature (600°C) along with 
elimination of carbon and organic components found in rice husk (Yusof et al., 
2010).  As proven by Yusof et al. (2010) through thermogravimetric analysis, RHA 
that was prepared from plug flow reactor or furnace (RHA-PFC) has very low 
impurities when compared to RHA prepared by the open burning method (RHA-
OB).  RHA-PFC showed minor total weight loss after ignition (≈ 12%) whereas 
RHA-OB recorded a higher amount of total weight loss (50%) after ignition, 
indicating that there were less impurities in RHA-PFC than in RHA-OB and thus, 
RHA-PFC was suitable to be used as the source of silica for the synthesis of highly 
pure zeolites.  Hence, in this research, the aim was to synthesize pure nanozeolite 
NaY that has higher anticancer activity than the currently available synthetic zeolites 
as an alternative to the natural zeolite clinoptilolite, using an organic template-free 
method and RHA as the silica source, which is more environmentally friendly and 
cheaper in cost. 
Each type of zeolites has different Si/Al ratio.  Zeolite with a low Si/Al ratio 
would have a high negative charge due to the high number of aluminium, and thus a 
high number of exchangeable cations in the extraframework (Meinander, 2014).  It 
was hypothesized that the mechanism for zeolite antiproliferation activity against the 
cancer cells might be related to the adsorption of serum components since the 
activity was detected only in the presence of serum (Katic et al., 2006).  As an 
adsorbent, the mechanism for the adsorption of cations by zeolites is through ion 
exchange (Meinander, 2014).  Therefore, zeolites with low ratio of Si/Al were 
selected as they have higher cation exchange capacity compared to zeolites with high 
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Si/Al ratio (Breck, 1974).  Besides that, the pore size of the zeolites was also 
considered.  Zeolites with large pores such as zeolites X and Y (0.6-0.8 nm) would 
allow large molecules to be adsorbed into their pores while zeolite with small pore 
size such as zeolite A (0.35-0.45 nm) might prevent large molecules from entering its 
pore (Flanigen, 2001; Breck, 1974).  Zeolites in the sodium form would give an 
advantage due to the low electronegativity of the sodium ion, which means it could 
be easily replaced by other cations (Meinander, 2014). 
The efficacy of the application through oral consumption is of the main 
concern once the selected nanozeolite is synthesized.  The nanozeolite is expected to 
be unstable in the acidic environment of the stomach due to the alkaline nature of the 
nanozeolite.  The structure of the nanozeolite may collapse as the extraframework 
cations of the nanozeolite would be replaced by the hydronium ions and followed by 
dealumination (Colella, 2011).  On the other hand, the basic condition of the 
intestinal tract would favor the dissolution of nanozeolite releasing the silicate and 
aluminate from the nanozeolite framework (Colella, 2011).  It is also important to 
ensure that the application of zeolite will not interfere with the biological 
environment that will affect the physiological aspect.  Thus, the challenge is to attain 
the concentration that is structurally stable, tolerable to the gastrointestinal condition 
and capable of inhibiting the proliferation of cancer cells.  In order to ensure the 
stability of the zeolite structure, zeolite NaY (Si/Al: 1.5-3.0) was selected instead of 
zeolite NaX (Si/Al: 1-1.5) or zeolite NaA (Si/Al: 1), due to its higher Si/Al ratio.  
Dissolution or disintegration of the framework is highly dependent on the Si/Al ratio 
of the zeolite, where zeolites with higher Si/Al ratio such as zeolite Y were found to 
be more stable in acidic solution compared to zeolites with low Si/Al such as zeolite 
A (Hartman and Fogler, 2007). 
The antiproliferative activity of nanozeolites is normally cell type-dependent 
and dose-dependent (Petushkov et al., 2009).  They were found to be non-toxic to the 
cells at low concentrations (Laurent et al., 2013), but cytotoxicity at concentrations 
above 0.5 mg/ml had been reported (Thomassen et al., 2012).  Therefore, the 
question whether the antiproliferative activity of the synthesized nanozeolite will 
remain after passing through the gastrointestinal tract is an additional concern.  A 
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study by Kavak and Ulku (2013) showed an insignificant decrease in the 
antiproliferative activity of digested zeolite.  Thus, a slight decrease in the 
antiproliferation activity would be expected, but most importantly the synthesized 
nanozeolite must have low toxicity against the normal cells for it to function as an 
anticancer adjuvant alternative to the clinoptilolite. 
1.3 Objectives of Research 
The main objective of this research is to characterize and determine the 
potential of a synthetic nanozeolite as an alternative adjuvant therapy for cancer.  
These are the four sections of the main objective: 
1. To screen selected synthetic zeolites (CBV300, CP814E and Zeo-NaY) for 
antiproliferative activity. 
2. To synthesize and characterize synthetic nanozeolite (Nano-NaY). 
3. To study the effects of the synthesized nanozeolite (Nano-NaY) after 
incubation in simulated gastrointestinal fluid. 
4. To study the antiproliferation ability and cytotoxicity of the synthesized 
nanozeolite (Nano-NaY) before and after incubation in simulated 
gastrointestinal fluid. 
1.4 Scope of Research 
The research was focused on the characterization of a synthetic nanozeolite 
(Nano-NaY) for biomedical application as an alternative adjuvant in cancer therapy.  
A preliminary study was performed using commercial synthetic zeolites Y 
(CBV300) and beta (CP814E) at different concentrations to screen for the 
antiproliferative ability of the zeolites against cancer cells via in vitro proliferation 
test.  Another zeolite Y (Zeo-NaY) that was previously synthesized using RHA as 
the silica source was also included in the testing.  Established cell lines of the 
cervical carcinoma (HeLa), pancreatic adenocarcinoma (BxPC-3), breast 
adenocarcinoma (MDA-MB-231, MDA-MB-468, and MCF-7), colorectal 
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adenocarcinoma (HT-29) and Chinese hamster ovary (CHO-K1) were used to 
measure the range of anticancer activity by the synthetic zeolites against the cell 
lines.  All the synthetic zeolites were initially characterized to confirm their identity 
and purity. 
The first scope started with the synthesis of a synthetic nanozeolite and ended 
with the study on the structural and morphological stability of the synthesized 
nanozeolite in the simulated gastrointestinal fluid.  A novel nanozeolite NaY (Nano-
NaY) was synthesized using RHA (prepared from plug flow reactor) as the silica 
source through an organic template-free method.  Several modifications were made 
to a previous hydrothermal method.  Different forms of RHA were used and 
optimization of the aging time, as well as the crystallization temperature, were 
performed in order to reduce the particle size of the final product.  The final product 
attained was then characterized for identification. 
Subsequently, the stability of Nano-NaY in gastrointestinal condition was 
studied using simulated gastric fluid (SGF) and simulated intestinal fluid (SIF).  The 
pH of both simulated fluids was measured prior to and after the incubation with 
Nano-NaY.  Samples of Nano-NaY from both of the simulated fluids were taken for 
characterization and samples from both simulated fluids were also taken for 
elemental analysis.  The Nano-NaY was then incubated in simulated gastrointestinal 
fluid (SGIF) by incubating the nanozeolites in SGF and SIF subsequently.  This was 
performed in order to mimic the actual gastrointestinal condition before performing 
further tests using the Nano-NaY that had been immersed in SGIF (NanoNaY-SGIF). 
The second scope covers the study on the potential of the synthesized Nano-
NaY for biomedical application, started with the preparation of nanozeolite-treated 
media and ended with the antiproliferative activity and cytotoxicity study of the 
nanozeolite via in vitro proliferation test.  Nanozeolite-treated media was prepared 
by mixing Nano-NaY with the cell culture media.  Dulbecco’s modified essential 
medium (DMEM) was used to cultivate the normal liver cell lines (WRL-68) while 
Roswell Park Memorial Institute medium (RPMI) was used to cultivate the colorectal 
adenocarcinoma cell lines (HT-29).  Samples of the Nano-NaY after being used to 
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treat DMEM (NanoNaY-DMEM) and samples of the Nano-NaY after being used to 
treat RPMI (NanoNaY-RPMI) were taken for characterization.  Both nanozeolite-
treated media were also sent for elemental analysis.  The procedures were repeated 
for NanoNaY-SGIF with the samples labeled as NanoNaY-SGIF-DMEM and 
NanoNaY-SGIF-RPMI. 
Antiproliferation activity of the Nano-NaY and NanoNaY-SGIF against HT-
29 and toxicity against WRL-68 were tested using the MTT assay and LDH assay.  
The half maximal inhibitory concentration (IC50) of both Nano-NaY and NanoNaY-
SGIF were then calculated and analyzed. The amount of LDH released were also 
calculated and analyzed. 
1.5 Significance of Research 
The research was performed with the aim to synthesize, characterize and 
study the potential of a synthetic nanozeolite as an alternative to clinoptilolite for the 
application as an anticancer adjuvant with improvement in purity, crystallinity and 
antiproliferation activity.  The efficiency of the synthetic nanozeolite as anticancer 
adjuvant was then assessed by studying its stability in simulated gastrointestinal fluid 
and measuring its cytotoxicity via in vitro tests.  Figure 1.1 shows the contribution of 
the research in the vicinity of all the research for cancer treatments. 
 
Figure 1.1 Contribution of the research 
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